Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor

ClinicalTrials.gov ID: NCT00754325

Public ClinicalTrials.gov record NCT00754325. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor

Study identification

NCT ID
NCT00754325
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
100 participants

Conditions and interventions

Interventions

  • Dasatinib Drug
  • Fulvestrant Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2008
Primary completion
Oct 31, 2011
Completion
Dec 31, 2013
Last update posted
May 25, 2016

2008 – 2014

United States locations

U.S. sites
28
U.S. states
11
U.S. cities
25
Facility City State ZIP Site status
Northern Arizona Hematology & Oncology Associates Sedona Arizona 86336-4937
Arizona Oncol Assoc Dba (Hem Onc Physicians&Extenders) Hope Tucson Arizona 85704
Florida Cancer Institute - New Hope Hudson Florida 34667-6594
Cancer Centers Of Florida, P.A Ocoee Florida 34761
Central Indiana Cancer Centers Carmel Indiana 46032
Kansas City Cancer Center, Llc. Overland Park Kansas 66210
Minnesota Oncology Hematology, P.A. Minneapolis Minnesota 55404
Missouri Cancer Associates Columbia Missouri 65201
New York Oncology Hematology, Pc Troy New York 12180
Raleigh Hematology Oncology Associates Raleigh North Carolina 27607
Willamette Valley Cancer Center Eugene Oregon 97401
Northwest Cancer Specialists, P.C. Portland Oregon 97213
Texas Oncology-Central Austin Cancer Center Austin Texas 78731
Texas Oncology, P.A. Bedford Texas 76022
Texas Oncology, P.A. Dallas Texas 75230-2510
Texas Oncology Dallas Texas 75231
Texas Oncology Sammons Cancer Center Dallas Texas 75246
Texas Cancer Center Denton Texas 76210
El Paso Cancer Treatment Ctr - West El Paso Texas 79902
Us Oncology Research, Inc. Houston Texas 77060
Quest Diagnostic Clinical Laboratories Inc Houston Texas 77072
Cancer Care Centers Of South Texas San Antonio Texas 78217
Tyler Cancer Center Tyler Texas 75702
Texas Oncology Cancer Care And Research Center Waco Texas 76712
Texas Oncology, P.A. Webster Texas 77598-4420
Virginia Oncology Associates Norfolk Virginia 23502
Oncology & Hematology Associates Of Southwest Virginia, Inc. Salem Virginia 24153
Virginia Center Specialists, Pc Woodbridge Virginia 22191

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00754325, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 25, 2016 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00754325 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →